Skip to main content

Published locations for FDA approves Brukinsa for relapsed, refractory MCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves Brukinsa for relapsed, refractory MCL

User login

  • Reset your password
  • /content/fda-approves-brukinsa-relapsed-refractory-mcl
  • /hematologynews/article/212411/mantle-cell-lymphoma/fda-approves-brukinsa-relapsed-refractory-mcl
  • /oncologypractice/article/212411/mantle-cell-lymphoma/fda-approves-brukinsa-relapsed-refractory-mcl
  • /hematology-oncology/article/212411/mantle-cell-lymphoma/fda-approves-brukinsa-relapsed-refractory
  • /hematologytimes/article/212411/mantle-cell-lymphoma/fda-approves-brukinsa-relapsed-refractory-mcl
  • /b-cell-lymphoma-icymi/article/212411/mantle-cell-lymphoma/fda-approves-brukinsa-relapsed-refractory